{
"info": {
"nct_id": "NCT02222272",
"official_title": "Effect of Prior Therapy With Nilotinib or Dasatinib on the Outcome After Allogeneic Stem Cell Transplantation for Patients With Chronic Myeloid Leukaemia",
"inclusion_criteria": "* All adult patients with chronic myeloid leukaemia in any phase (chronic, accelerated or blastic) who undergo allogeneic stem cell transplantation between 01/01/2010 and 30/09/2013 and have been previously treated with Nilotinib or Dasatinib, regardless of their response to these drugs.\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
"exclusion_criteria": "",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"line": "* All adult patients with chronic myeloid leukaemia in any phase (chronic, accelerated or blastic) who undergo allogeneic stem cell transplantation between 01/01/2010 and 30/09/2013 and have been previously treated with Nilotinib or Dasatinib, regardless of their response to these drugs.",
"criterions": [
{
"exact_snippets": [
"adult patients"
],
"criterion": "age",
"requirement_type": "category",
"expected_value": "adult"
},
{
"exact_snippets": [
"chronic myeloid leukaemia"
],
"criterion": "chronic myeloid leukaemia",
"requirement_type": "presence",
"expected_value": true
},
{
"exact_snippets": [
"chronic myeloid leukaemia",
"in any phase (chronic, accelerated or blastic)"
],
"criterion": "chronic myeloid leukaemia phase",
"requirement_type": "category",
"expected_value": [
"chronic",
"accelerated",
"blastic"
]
},
{
"exact_snippets": [
"undergo allogeneic stem cell transplantation"
],
"criterion": "allogeneic stem cell transplantation",
"requirement_type": "procedure",
"expected_value": true
},
{
"exact_snippets": [
"between 01/01/2010 and 30/09/2013"
],
"criterion": "transplantation date",
"requirement_type": "range",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 20100101
},
{
"operator": "<=",
"value": 20130930
}
]
}
},
{
"exact_snippets": [
"previously treated with Nilotinib or Dasatinib"
],
"criterion": "treatment",
"requirement_type": "previous",
"expected_value": [
"Nilotinib",
"Dasatinib"
]
}
]
},
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": [
"Healthy volunteers allowed"
],
"criterion": "healthy volunteers",
"requirement_type": "participation",
"expected_value": true
}
]
},
{
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": [
"minimum age of 18 Years"
],
"criterion": "age",
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18
}
}
]
}
],
"exclusion_lines": [],
"miscellaneous_lines": [],
"failed_inclusion": [],
"failed_exclusion": [],
"failed_miscellaneous": []
}